Anacor Pharma Reports Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Conferences
September 29, 2015 at 08:31 AM EDT
Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) announced today that data from the Phase 3 pivotal studies of investigational drug ...